$36.13
Today
as of Sep 4, 16:50 ET
Last 30 days
Recent Press Releases & News
Immunocore to present at upcoming investor conferences
Immunocore's Q2 Earnings Miss Estimates, Kimmtrak Aids Y/Y Revenues
Wall Street Analysts See a 77.91% Upside in Immunocore (IMCR): Can the Stock Really Move This High?
Overview
52-week range
$28
$41
65% of range
Avg surprise (last 3)
+109.8%
Avg reaction (last 2)
+6.6%
100% positive
Latest IV / EM
57%
EM ±8.9% · $35 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.02 | — | — | — | — | financials |
| Wed May 6, 2026 | Mar/2026 | $0.25 | $-0.26 | +196.2% | +150.0% | +6.6% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | — | — | — | — | — | financials |
| Thu Aug 7, 2025 | Jun/2025 | $-0.20 | $-0.21 | +4.8% | — | — | earnings |
| Wed May 7, 2025 | Mar/2025 | $0.10 | $-0.35 | +128.6% | — | +6.6% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $0.17 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.23 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.49 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $0.02 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.35 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.40 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $116M | $107M | — | $104M | $98M | $94M | — | $80M |
| Cost of revenue | $1M | $434,000 | — | $513,000 | $1M | $831,000 | — | $448,000 |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-3M | $7M | — | $-7M | $-15M | $-4M | — | $-9M |
| Net income | $-808,000 | $13M | — | $-177,000 | $-10M | $5M | — | $9M |
| EPS (diluted) | $-0.02 | $0.25 | — | — | $-0.20 | $0.10 | — | $0.17 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $485M | $453M | $468M | $498M | $488M | $477M | $456M | $538M |
| Inventory | $8M | $8M | $7M | $6M | $5M | $7M | $5M | $5M |
| Total current assets | $1.05B | $1.00B | $997M | $1.02B | $1.00B | $949M | $930M | $1.01B |
| Total assets | $1.12B | $1.07B | $1.07B | $1.10B | $1.08B | $1.03B | $1.01B | $1.08B |
| Long-term debt | — | — | — | — | — | — | — | $439M |
| Total liabilities | $700M | $678M | $686M | $706M | $694M | $650M | $649M | $707M |
| Total equity | $420M | $394M | $381M | $397M | $388M | $378M | $361M | $378M |